KR890009904A - 광학적 활성 3-데메틸메발론산 유도체, 및 중간 생성물의 제조방법 - Google Patents

광학적 활성 3-데메틸메발론산 유도체, 및 중간 생성물의 제조방법 Download PDF

Info

Publication number
KR890009904A
KR890009904A KR1019880016302A KR880016302A KR890009904A KR 890009904 A KR890009904 A KR 890009904A KR 1019880016302 A KR1019880016302 A KR 1019880016302A KR 880016302 A KR880016302 A KR 880016302A KR 890009904 A KR890009904 A KR 890009904A
Authority
KR
South Korea
Prior art keywords
formula
carbon atoms
compound
radical
alkyl
Prior art date
Application number
KR1019880016302A
Other languages
English (en)
Other versions
KR970008314B1 (ko
Inventor
베쓰 퀸터
케쎌러 쿠르트
바더 에케아르트
벡크 게르하르트
Original Assignee
하인리히 벡커
훽스트 아크티엔게젤샤프트
베른하이르트 벡크
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하인리히 벡커, 훽스트 아크티엔게젤샤프트, 베른하이르트 벡크 filed Critical 하인리히 벡커
Publication of KR890009904A publication Critical patent/KR890009904A/ko
Application granted granted Critical
Publication of KR970008314B1 publication Critical patent/KR970008314B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)

Abstract

내용 없음

Description

광학적 활성 3-데메틸메발론산 유도체, 및 중간 생성물의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

1) 일반식(Ⅵ)의 디올 에스테르를 공지방법 자체로 통상적 보호그룹을 도입시켜 일급 알콜 그룹상에서 보호된 일반식(Ⅶ) 화합물로 전환시키고, 2) 일반식(Ⅶ)의 생성 화합물 또는 이의 상응하는 알콜레이트를 t-부틸아세테이트 또는 적절한 등가물로 통상적 축합반응시켜 일반식(Ⅷ) 화합물로 전환시키고, 3) 일반식(Ⅷ)의 생성된 하이드록시 케토에스테르를 공지방법 자체로 일반식(Ⅸ)의 1,3-디올에스테르로 환원시키고, 4) 일반식(Ⅸ)의 생성된 1,3-디올 에스테르를 1,3-디올에 적합한 보호그룹을 도입시켜 일반식(Ⅹ)의 화합물로 전환시키고, 5) 일반식(Ⅹ)의 생성화합물을 통상적 방법으로 보호그룹 R2를 제거하여 일반식(Ⅲ)의 화합물로 전환시키고, 6) 일반식(Ⅲ)의 생성 화합물을 일반식(XI)의 올레핀 유도체로 전환시키고, 7) 일반식(XI)의 생성화합물을 가수분해시켜 Y가 CH=CH 그룹으로, R1이 C1-C8-알킬 라디칼인 일반식(Ⅰ)의 화합물을 수득하고, 8) 경우에 따라 Y가 CH=CH 그룹인 일반식(Ⅰ)의 생성 화합물을 수소화반응시켜 Y가 CH2-CH2그룹인 일반식(Ⅰ) 화합물을 수득하고, 9) 경우에 따라 생성 화합물을 산(R1=H) 또는 염(R1=금속 양이온)으로 전환시키고, 10) 경우에 따라 일반식(Ⅰ)의 생성 화합물을 일반식(Ⅱ)의 화합물로 전환시킴을 특징으로 하여, 일반식(Ⅰ) 또는 일반식(Ⅱ)의 광학적 활성 3-데메틸 메발론산 유도체를 제고하는 방법.
상기식에서, Y는 -CH=CH- 또는 -CH2-CH2-그룹이고, R은 일반식(α) 또는 (β)의 라디칼이고,
Z는 구조식 -CH의 라디칼이거나 질소원자이고, R3,R4및 R5는 서로 독립적으로, 수소, 탄소수 3 내지 6의 포화 또는 불포화 환식 탄화수소 라디칼에 의해 말단 탄소에서 임의로 치환될 수 있는 탄소수 6이하의 직쇄 또는 측쇄 탄화수소 라디칼이거나, 탄소수 3 내지 7 이하의 환식 포화되거나 이중으로 불포화된 탄화수소 라디칼, 할로겐, 트리플루오로메틸, 각각의 경우 탄소수 6이하의 알킬 또는 알케닐, 하이드록실, 탄소수 1 내지 6의 알콕시, 카복실, 또는 알콕시 잔기중의 탄소수가 1 내지 6인 카브알콕시중에서 선택된 동일하거나 상이한 1 내지 3개의 치환체들을 핵중에 임의로 함유할 수 있는 페닐, 푸릴, 티에닐 및 피리딜중에서 선택된 방향족 라디칼이고, A-B는 -CH-CH- 또는 -C=C- 그룹이고, R6및 R7는 동일하거나 상이하고, 탄소수 1 내지 6의 알콕시 그룹 또는 그룹(여기에서, R9은 탄소수 1 내지 8의 알킬이다)에 의해 치환될 수 있는 탄소수 20이하의 포화되거나 불포화된 알킬 라디칼이거나, 방향족 라디칼이 할로겐, 각각의 경우 탄소수 1 내지 6의 알킬 또는 알콕시, 탄소수 3 내지 7의 사이클로알킬 또는 그룹(여기에서, R9는 탄소수 1 내지 8의 알킬이다)에 의해 핵중에서 1 내지 3회 치환될 수 있는 탄소수 3 내지 7의 사이클로알킬 라디칼, 페닐, 티에닐, 푸릴 또는 나프틸 라디칼, 또는 탄소수 1 내지 4의 알킬에 의해 핵중에서 1 내지 3회 치환될 수 있는 피리딜 라디칼이고, R8은 탄소수 8이하의 포화되거나 불포화된 알킬 라디칼, 할로겐, 각각의 경우 탄소수 1 내지 4의 알콕시 또는 알킬에 의해 핵중에서 1 내지 3회 치환될 수 있는 벤질 라디칼, 페닐, 티에틸, 푸릴 또는 나프틸 라디칼(여기에서, 방향족 라디칼을 각각의 경우 할로겐, 탄소수 1 내지 4의 알콕시 또는 알킬 또는 탄소수 3 내지 7의 사이클로알킬 라디칼에 의해 핵중에서 1 내지 3회 치환될 수 있다)이며, R1은 수소, 금속 양이온 또는 탄소수 1 내지 8의 알킬 라디칼이고, 일반식(Ⅵ),(Ⅶ),(Ⅷ),(Ⅸ),(Ⅹ),(Ⅲ) 및 (Ⅵ)에서, R1은 C1-C8-알킬이고, R2는 통상의 알콜 보호그룹이며, M은 1,3-디올류에 대한 적절한 보호그룹이다.
일반식(XII)의 알데히드.
상기식에서, M은 하기 구조식
의 라디칼이다.
M이 일반식(XII)에서 나타낸 정의를 갖는 일반식(Ⅲ)의 알콜을 산화시킴을 특징으로하여, 일반식(XII)의 알데히드를 제조하는 방법.
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019880016302A 1987-12-08 1988-12-08 광학적 활성 3-데메틸메발론산 유도체 및 중간 생성물의 제조방법 KR970008314B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3741509.3 1987-12-08
DE19873741509 DE3741509A1 (de) 1987-12-08 1987-12-08 Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte

Publications (2)

Publication Number Publication Date
KR890009904A true KR890009904A (ko) 1989-08-04
KR970008314B1 KR970008314B1 (ko) 1997-05-23

Family

ID=6342094

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880016302A KR970008314B1 (ko) 1987-12-08 1988-12-08 광학적 활성 3-데메틸메발론산 유도체 및 중간 생성물의 제조방법

Country Status (18)

Country Link
US (2) US4970313A (ko)
EP (1) EP0319847B1 (ko)
JP (2) JP2511510B2 (ko)
KR (1) KR970008314B1 (ko)
AT (1) ATE92045T1 (ko)
AU (2) AU616224B2 (ko)
CA (1) CA1340105C (ko)
DE (2) DE3741509A1 (ko)
DK (1) DK170616B1 (ko)
ES (1) ES2058222T3 (ko)
FI (1) FI92321C (ko)
HU (2) HU207045B (ko)
IE (1) IE62540B1 (ko)
IL (1) IL88612A (ko)
NO (1) NO174201C (ko)
NZ (1) NZ227210A (ko)
PT (1) PT89163B (ko)
ZA (1) ZA889120B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160040875A (ko) * 2014-10-06 2016-04-15 한양대학교 에리카산학협력단 다이플루오로알킬기가 도입된 유기 화합물의 제조 방법

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4906624A (en) * 1987-09-08 1990-03-06 Warner-Lambert Company 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
NO177005C (no) * 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
DE3826814A1 (de) * 1988-08-06 1990-02-08 Hoechst Ag Neue 6-fluor-3,5-dihydroxycarbonsaeuren und deren derivate, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte
DE3925636A1 (de) * 1989-08-03 1991-02-07 Bayer Ag Imino-substituierte pyridine
EP0469480A3 (en) * 1990-08-01 1993-03-10 Hoechst Aktiengesellschaft Process for stereoselective preparation of 5-substituted delta-lactones and their use
US5292898A (en) * 1990-08-01 1994-03-08 Hoechst Aktiengesellschaft Process for the stereoselective preparation of 5-substituted delta-lactones and use thereof
JPH054943A (ja) * 1990-08-30 1993-01-14 Sagami Chem Res Center 光学活性β，δ−ジケト酸エステル及びその還元体
JP2619136B2 (ja) * 1990-11-02 1997-06-11 鐘淵化学工業株式会社 ５，６―ジヒドロキシ―３―オキソヘキサン酸エステル誘導体の製造法
US5288928A (en) * 1990-12-21 1994-02-22 Ciba-Geigy Corporation Asymmetrical hydrogenation
DE4128345C1 (en) * 1991-08-27 1993-06-09 Hoechst Ag, 6230 Frankfurt, De 3R,5S 3,5,6-tri:hydroxy-hexanoic acid isopropylidene ketal derivs. prepn. - from 7-benzyl:oxy 4,6-di:hydroxy:heptene by multistage process
US5155251A (en) * 1991-10-11 1992-10-13 Warner-Lambert Company Process for the synthesis of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate
US5278313A (en) * 1992-03-27 1994-01-11 E. R. Squibb & Sons, Inc. Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors
DE59307409D1 (de) * 1992-07-02 1997-10-30 Hoechst Ag Verfahren zur Herstellung von (3R,5S)6-Hydroxy-3,5-0-isopropyliden-3,5-dihydroxy-hexansäure-tert.-butylester
JP3076154B2 (ja) * 1992-08-13 2000-08-14 高砂香料工業株式会社 （３ｒ，５ｓ）−３，５，６−トリヒドロキシヘキサン酸誘導体及びその製造方法
WO1996029299A1 (fr) * 1995-03-17 1996-09-26 Shionogi & Co., Ltd. Procede d'oxydation d'acides 6-hydroxyhexanoiques
DE19714343A1 (de) 1997-04-08 1998-10-15 Bayer Ag Chromatographische Enantiomerentrennung von Lactonen
PT1054860E (pt) * 1997-12-19 2007-06-22 Pfizer Ireland Pharmaceuticals Processo para a síntese 1, 2 dióis
DE69937374T2 (de) 1998-08-05 2008-07-24 Kaneka Corp. Verfahren zur Herstellung von 3,5-dihydroxy substituierten Estern als Zwischenprodukte zur Herstellung optisch aktiver 2-(6-(Hydroxymethyl)-1,3-dioxan-4-yl)-essigsäure-Derivate
GB9903472D0 (en) 1999-02-17 1999-04-07 Zeneca Ltd Chemical process
JP4659309B2 (ja) * 1999-06-04 2011-03-30 株式会社カネカ ５−ヒドロキシ−３−オキソペンタン酸誘導体の製造法
JP3844112B2 (ja) 2000-08-23 2006-11-08 高砂香料工業株式会社 ３，５，６−トリヒドロキシヘキサン酸アンモニウム塩誘導体、及びその製造方法
ITMI20010968A1 (it) * 2001-05-10 2002-11-10 Centonze Nicola Film mono o coestruso per la protezione temporanea o permanente di superfici in genere avente un aspetto estetico-funzionale simile alla car
DK1417180T3 (da) 2001-07-13 2007-04-10 Astrazeneca Uk Ltd Fremstilling af aminopyrimidinforbindelser
NZ534688A (en) * 2002-02-25 2005-04-29 Biocon Ltd Novel boronate esters
GB0211751D0 (en) * 2002-05-22 2002-07-03 Avecia Ltd Compound and process
GB0218781D0 (en) * 2002-08-13 2002-09-18 Astrazeneca Ab Chemical process
KR100529703B1 (ko) * 2002-09-23 2005-11-17 임광민 키랄 중간체의 제조방법 및 그를 이용한 아토바스타틴의제조방법
GB0312896D0 (en) 2003-06-05 2003-07-09 Astrazeneca Ab Chemical process
UY28501A1 (es) * 2003-09-10 2005-04-29 Astrazeneca Uk Ltd Compuestos químicos
GB0324791D0 (en) 2003-10-24 2003-11-26 Astrazeneca Ab Chemical process
CN1300133C (zh) * 2004-10-21 2007-02-14 浙江大学 （3r，5r）－3－羟基－5－氨乙基环戊内酯的合成方法
GB0428328D0 (en) 2004-12-24 2005-02-02 Astrazeneca Uk Ltd Chemical process
GB0514078D0 (en) * 2005-07-08 2005-08-17 Astrazeneca Uk Ltd Chemical process
US8455640B2 (en) * 2006-05-03 2013-06-04 Msn Laboratories Limited Process for statins and its pharmaceutically acceptable salts thereof
CN100429212C (zh) * 2006-06-30 2008-10-29 浙江东港药业有限公司 一种(4R-cis)-6-甲酰基-2,2-二甲基-1,3-二氧己环-4-乙酸叔丁酯的合成方法
WO2008059519A2 (en) * 2006-09-25 2008-05-22 Glenmark Pharmaceuticals Limited A process for the preparation of intermediates of rosuvastatin
US8404841B2 (en) * 2006-10-09 2013-03-26 Msn Laboratories Limited Process for the preparation of statins and their pharmaceutically acceptable salts thereof
WO2008059366A2 (en) * 2006-11-17 2008-05-22 Pfizer Products Inc. Process for the preparation of cis-1, 3-diols from the corresponding beta-hydroxy ketones employing microbial ketone reductases
EP2351762B1 (en) 2008-10-20 2013-10-16 Kaneka Corporation NOVEL PYRIMIDINE DERIVATIVE AND METHOD FOR PRODUCING HMG-CoA REDUCTASE INHIBITOR INTERMEDIATE
EP2387561A4 (en) 2009-01-19 2012-07-25 Msn Lab Ltd IMPROVED PROCESS FOR THE PREPARATION OF HIGH-PURITY (3R, 5S) -7-β-CYCLOPROPYL-4- (4-FLUOROPHENYL) QUINOLIN-3-YL-3,5-DIHYDROXY-6 (E) -HEPTENOIC ACID, INCLUDING ITS PHARMACEUTICALLY ACCEPTABLE SALTS
US8987444B2 (en) 2010-01-18 2015-03-24 Msn Laboratories Private Limited Process for the preparation of amide intermediates and their use thereof
CN103476763B (zh) 2011-04-01 2016-02-03 隆萨有限公司 以两步骤制备3,5-二氧代己酸酯
KR101292743B1 (ko) * 2012-05-17 2013-08-02 (주) 에프엔지리서치 신규한 스타틴 중간체 및 이를 이용한 피타바스타틴, 로수바스타틴, 세리바스타틴 및 플루바스타틴의 제조 방법
WO2014203045A1 (en) 2013-06-20 2014-12-24 Lupin Limited A novel, green and cost effective process for synthesis of tert-butyl (3r,5s)-6-oxo-3,5-dihydroxy-3,5-o-isopropylidene-hexanoate
CN104230879B (zh) * 2014-08-15 2016-08-24 新发药业有限公司 一种2-((4r, 6s)-6-甲酰基-2,2-二取代基-1,3-二氧六环-4-基)乙酸酯制备方法
CN105985311B (zh) * 2015-02-15 2019-08-13 北大医药股份有限公司 一种制备瑞舒伐他汀钙的中间体及其制备瑞舒伐他汀钙的方法
CN106317011B (zh) * 2015-06-25 2019-01-18 北大方正集团有限公司 一种瑞舒伐他汀钙中间体的制备方法
CN115894431A (zh) * 2022-11-29 2023-04-04 南京欧信医药技术有限公司 他汀类药物中间体的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4571428A (en) * 1983-07-08 1986-02-18 Sandoz, Inc. 6-Substituted-4-hydroxy-tetrahydropyran-2-ones
EP0244364A3 (en) * 1986-04-30 1992-04-01 Sandoz Ag Preparation of olefinic compounds
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
EP0307342B1 (de) * 1987-07-10 1996-01-03 Hoechst Aktiengesellschaft 3-Desmethyl-mevalonsäurederivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen, ihre Verwendung sowie Zwischenprodukte
US4906624A (en) * 1987-09-08 1990-03-06 Warner-Lambert Company 6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4824959A (en) * 1988-02-18 1989-04-25 Bristol-Myers Company Intermediates for antihypercholesterolemic tetrazole compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160040875A (ko) * 2014-10-06 2016-04-15 한양대학교 에리카산학협력단 다이플루오로알킬기가 도입된 유기 화합물의 제조 방법

Also Published As

Publication number Publication date
IE62540B1 (en) 1995-02-08
FI885651A0 (fi) 1988-12-05
NO885438D0 (no) 1988-12-07
EP0319847A3 (en) 1990-12-05
KR970008314B1 (ko) 1997-05-23
FI885651A (fi) 1989-06-09
IL88612A (en) 1992-11-15
CA1340105C (en) 1998-10-27
ATE92045T1 (de) 1993-08-15
HUT52495A (en) 1990-07-28
JPH08231534A (ja) 1996-09-10
FI92321C (fi) 1994-10-25
NZ227210A (en) 1991-02-26
EP0319847B1 (de) 1993-07-28
DE3741509A1 (de) 1989-06-22
NO174201C (no) 1994-03-30
US4977279A (en) 1990-12-11
PT89163B (pt) 1993-06-30
HU900272D0 (en) 1990-03-28
AU8141591A (en) 1991-10-17
NO174201B (no) 1993-12-20
HUT52056A (en) 1990-06-28
AU2662688A (en) 1989-06-08
AU639583B2 (en) 1993-07-29
EP0319847A2 (de) 1989-06-14
DE3882668D1 (de) 1993-09-02
US4970313A (en) 1990-11-13
DK682588A (da) 1989-06-09
JP2573819B2 (ja) 1997-01-22
JPH01199945A (ja) 1989-08-11
ES2058222T3 (es) 1994-11-01
DK170616B1 (da) 1995-11-13
HU202856B (en) 1991-04-29
HU207045B (en) 1993-03-01
ZA889120B (en) 1989-08-30
PT89163A (pt) 1989-09-14
AU616224B2 (en) 1991-10-24
IE883648L (en) 1989-06-08
IL88612A0 (en) 1989-07-31
DK682588D0 (da) 1988-12-07
FI92321B (fi) 1994-07-15
JP2511510B2 (ja) 1996-06-26
NO885438L (no) 1989-06-09

Similar Documents

Publication Publication Date Title
KR890009904A (ko) 광학적 활성 3-데메틸메발론산 유도체, 및 중간 생성물의 제조방법
KR890000364B1 (ko) 옥타히드로나프탈렌 유도체의 제조방법
KR890002119A (ko) 3-데메틸메발론산 유도체, 이의 제조방법, 이 화합물을 기본으로 하는 약제학적 조성물, 이의 용도 및 중간체
KR910001037A (ko) 포스포리파아제a₂억제제
FR2487349A1 (fr) Derives de l'hydronaphtalene, leur preparation et leur utilisation en therapeutique
KR930701460A (ko) 광학활성의 중간체 및 그의 제조방법
US2576103A (en) Synthesis of vitamin a active compounds containing repeated isoprene units
KR890011859A (ko) 3,5-디하이드록시 카복실산 및 이의 유도체, 이의 제조방법, 약물로서의 이의 용도, 약제학적 생성물 및 중간체
KR880007453A (ko) 2,5,6,7-테트라노르-18,18,19,19-테트라데히드로-4,8-인터-m-페닐렌PGI2-유도체
KR840005122A (ko) 메틸플라본 유도체의 제조방법
Shimizu et al. Isolation and structure of macommelins, novel metabolites of Macrophoma commelinae
KR900011751A (ko) 선택적 에테르화 반응
EP0585104B1 (en) A method of preparing a saturated monocyclic hydrocarbon compound and an intermediate therefor
KR920002508A (ko) 2,4-디히드록시아디프산 유도체
US4255334A (en) Process for preparing 3-azabicyclo(3.1.0)hexane-2-carboxylic acid
FI822567A0 (fi) Ml-236b derivater och foerfarande foer deras framstaellning
US3576880A (en) 5(2,6,6-trimethyl - 1 - hydroxy-cyclohex-2-enyl) -3 methyl-penta-2,4-dien-1-al derivatives
KR840002813A (ko) 신규 퀴놀린 초산 유도체의 제조법
RU2007110644A (ru) Способ получения диарилциклоалкилпроизводных
KR890000508A (ko) 사카로 아스코르브산 에스테르, 그의 제조방법 및 용도
Aparicio et al. Photo-oxygenation of glycosylfurans. Rearrangement of C-glycosyl into O-glycosyl derivatives
USRE30339E (en) Conversion of acid S, produced by the organism Polyangium cellulosum var. fulvum into acid F
US4166061A (en) Use of cyclic esters to prepare 2,3-dichloro-4-(2-thenoyl)phenoxyacetic acid
Nguyen et al. A synthesis of l-(+)-quinic acid from d-(–)-quinic acid
El-Emary et al. Microbiological Transformation of (-)-Kaur-16-en-19-oic Acid

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20110811

Year of fee payment: 15

EXPY Expiration of term